EBRD invests EUR 24 million in Greece’s Famar

The European Bank for Reconstruction and Development (EBRD), alongside MidEuropa and other investors, is supporting, with an equity investment of EUR 24 million, the acquisition in Greece of Famar, a leading pharmaceutical contract development and manufacturing organisation (CDMO).

Headquartered in Greece and with production sites in Greece, Italy and Spain, Famar is a leading pharmaceutical CDMO, focusing on the manufacturing and distribution of a wide range of pharmaceutical, consumer health and cosmetic products.

Under the new ownership, Famar plans to make substantial investments in Greece to expand both its R&D and sterile manufacturing capabilities, among others, as the company continues to shift its product mix towards higher-value-added products.